Epigenetic strategies synergize with PD-L1/PD-1 targeted cancer immunotherapies to enhance antitumor responses

• Автори: Xi Chen (Автор), Xiaohui Pan (Автор), Wenxin Zhang (Автор), Hongjie Guo (Автор), Shuyuan Cheng (Автор), Qiaojun He (Автор), Bo Yang (Автор), Ling Ding (Автор)
• Формат: Книга
• Опубліковано: Elsevier, 2020-05-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

Immunotherapy strategies targeting the programmed cell death ligand 1 (PD-L1)/programmed cell death 1 (PD-1) pathway in clinical treatments have achieved remarkable success in treating multiple types of cancer. However, owing to the heterogeneity of tumors and individual immune systems, PD-L1/PD-1 b...